Concepedia

Tu Dai

TD

Statistics

Publications

6

Citations

223

H-Index

6

Active since

2016

Affiliations

Nanjing Medical University(Current)

Shanghai University of Traditional Chinese Medicine

Traditional Chinese Medicine Hospital of Kunshan

Wuxi No.2 People's Hospital

Second Hospital of Shanxi Medical University

Tu Dai is an author at Nanjing Medical University specializing in medicine, oncology, and noncoding rna in cancer.

Publications per year

2016–2021

6

Publications

6

<i>Retracted:</i> LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR‐96/<i>FOXO3</i>

Yongping Zhou, Yigang Chen, Wenzhou Ding et al. · IUBMB Life · 2018 · 80 citations · Full text

, , +17

Inhibition of BDNF-AS Provides Neuroprotection for Retinal Ganglion Cells against Ischemic Injury

Lifang Xu, Ziyin Zhang, Tianhua Xie et al. · PLoS ONE · 2016 · 35 citations · Full text

, , +15

LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1

Yongping Zhou, Huang Yonggang, Tu Dai et al. · Biomedicine & Pharmacotherapy · 2020 · 35 citations · Full text

, , +17

LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis

Yongping Zhou, Kuan Li, Xuexia Zou et al. · Bioengineered · 2021 · 32 citations · Full text

, , +17

Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A

Yongping Zhou, Kuan Li, Tu Dai et al. · Aging · 2021 · 27 citations · Full text

, , +17

1–5 of 6